With many rare diseases still lacking treatments, regulatory agencies are stepping up with new guidances to support innovation, advance research, and improve patient outcomes.
The impact of the latest guidances on rare clinical research
Study design strategies to ensure efficiency and compliance
A medic's perspective on what the changes will mean for patients and investigators
Current developments and 2024 approval trends
Premier Research, a clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
